2023 Q4 Form 20-F Financial Statement

#000141057824000556 Filed on April 29, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $104.9K $144.9K
YoY Change -76.72% -67.85%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $497.3K $1.393M
YoY Change -78.96% -41.08%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $37.56K $76.25K
YoY Change 60.24% 110.37%
% of Gross Profit
Operating Expenses $534.9K $1.469M
YoY Change -77.72% -38.8%
Operating Profit -$1.324M
YoY Change -32.08%
Interest Expense $35.56K $35.24K
YoY Change 198.07% 195.39%
% of Operating Profit
Other Income/Expense, Net $27.44K $174.5K
YoY Change 71.39% -186.61%
Pretax Income -$367.0K -$1.150M
YoY Change -82.94% -46.56%
Income Tax -$240.00 $10.84K
% Of Pretax Income
Net Earnings -$366.8K -$1.160M
YoY Change -82.97% -46.13%
Net Earnings / Revenue -349.62% -801.06%
Basic Earnings Per Share -$0.10
Diluted Earnings Per Share -$0.03 -$0.10
COMMON SHARES
Basic Shares Outstanding 11.68M 11.68M
Diluted Shares Outstanding 11.68M

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $503.5K $503.5K
YoY Change -64.87% -64.87%
Cash & Equivalents $499.7K $503.5K
Short-Term Investments
Other Short-Term Assets $11.77K $11.77K
YoY Change -55.95% -55.95%
Inventory
Prepaid Expenses
Receivables $164.2K $164.2K
Other Receivables $3.069K $3.070K
Total Short-Term Assets $682.5K $682.5K
YoY Change -72.61% -72.61%
LONG-TERM ASSETS
Property, Plant & Equipment $3.307M $3.307M
YoY Change 5.67% 5.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.362K
YoY Change -30.5%
Total Long-Term Assets $3.317M $3.317M
YoY Change 5.52% 5.52%
TOTAL ASSETS
Total Short-Term Assets $682.5K $682.5K
Total Long-Term Assets $3.317M $3.317M
Total Assets $3.999M $3.999M
YoY Change -29.03% -29.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $101.1K $101.1K
YoY Change -33.76% -33.76%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $122.0K $122.0K
YoY Change -82.71% -82.71%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $122.0K $122.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $122.0K $122.0K
YoY Change -82.71% -82.71%
SHAREHOLDERS EQUITY
Retained Earnings -$3.363M
YoY Change 52.68%
Common Stock $11.68K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.877M $3.877M
YoY Change
Total Liabilities & Shareholders Equity $3.999M $3.999M
YoY Change -29.03% -29.03%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$366.8K -$1.160M
YoY Change -82.97% -46.13%
Depreciation, Depletion And Amortization $37.56K $76.25K
YoY Change 60.24% 110.37%
Cash From Operating Activities -$334.4K -$599.4K
YoY Change -49.09% -62.24%
INVESTING ACTIVITIES
Capital Expenditures $61.48K $106.5K
YoY Change 35.09% 134.1%
Acquisitions
YoY Change
Other Investing Activities $63.46K $67.76K
YoY Change -102.19% -102.21%
Cash From Investing Activities $1.980K -$38.78K
YoY Change -100.07% -98.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.940K -363.1K
YoY Change 1426.92% -195.11%
NET CHANGE
Cash From Operating Activities -334.4K -599.4K
Cash From Investing Activities 1.980K -38.78K
Cash From Financing Activities 7.940K -363.1K
Net Change In Cash -324.4K -929.7K
YoY Change -90.99% -78.43%
FREE CASH FLOW
Cash From Operating Activities -$334.4K -$599.4K
Capital Expenditures $61.48K $106.5K
Free Cash Flow -$395.8K -$705.9K
YoY Change -43.63% -56.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11675216
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11675216
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164170
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
967819
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
11765
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
11675216
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001741534
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2023 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11675216
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11675216
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11675216
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2023 dei Document Type
DocumentType
20-F
CY2023 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38768
CY2023 dei Entity Registrant Name
EntityRegistrantName
MDJM LTD
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
Fernie Castle, Letham
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Cupar, Fife, KY15 7RU
CY2023 dei Entity Address Country
EntityAddressCountry
GB
CY2023 dei Security12b Title
Security12bTitle
Ordinary Shares
CY2023 dei Trading Symbol
TradingSymbol
MDJH
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11675216
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023 dei Auditor Firm
AuditorFirmId
587
CY2023 dei Auditor Name
AuditorName
RBSM LLP
CY2023 dei Auditor Location
AuditorLocation
New York, New York
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
503505
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1433158
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47199
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
231937
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
26721
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3069
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
64023
CY2023Q4 us-gaap Assets Current
AssetsCurrent
682509
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2491721
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3307371
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3129884
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11121
CY2023Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
9362
CY2022Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
2349
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9362
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13470
CY2023Q4 us-gaap Assets
Assets
3999242
CY2022Q4 us-gaap Assets
Assets
5635075
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
101969
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
313086
CY2023Q4 us-gaap Deferred Income
DeferredIncome
20068
CY2022Q4 us-gaap Deferred Income
DeferredIncome
20179
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
372679
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
122037
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
705944
CY2023Q4 us-gaap Liabilities
Liabilities
122037
CY2022Q4 us-gaap Liabilities
Liabilities
705944
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11675216
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
11675
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
11675
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6845394
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6845394
CY2023Q4 mdjh Statutory Reserve
StatutoryReserve
327140
CY2022Q4 mdjh Statutory Reserve
StatutoryReserve
327140
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3363436
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2202990
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
56432
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52088
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
3877205
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4929131
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3999242
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5635075
CY2023 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
144863
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
450634
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4466233
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
63
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10219
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
47480
CY2023 mdjh Payroll Payroll Taxes And Others
PayrollPayrollTaxesAndOthers
572240
CY2022 mdjh Payroll Payroll Taxes And Others
PayrollPayrollTaxesAndOthers
1370972
CY2021 mdjh Payroll Payroll Taxes And Others
PayrollPayrollTaxesAndOthers
5554186
CY2023 us-gaap Professional Fees
ProfessionalFees
525625
CY2022 us-gaap Professional Fees
ProfessionalFees
555657
CY2021 us-gaap Professional Fees
ProfessionalFees
460274
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
117686
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76246
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
36243
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
24910
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-159509
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
165464
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59625
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
454355
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
261610
CY2021 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
471557
CY2023 us-gaap Operating Expenses
OperatingExpenses
1469020
CY2022 us-gaap Operating Expenses
OperatingExpenses
2400165
CY2021 us-gaap Operating Expenses
OperatingExpenses
6735718
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1324157
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1949531
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-2269485
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
10954
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
18762
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
43548
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14402
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-240431
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-8350
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
16476
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-31615
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2094
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
139320
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
16011
CY2021 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
47340
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
174546
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-201533
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
26682
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1149611
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2151064
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2242803
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10835
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3020
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9963
CY2023 us-gaap Profit Loss
ProfitLoss
-1160446
CY2022 us-gaap Profit Loss
ProfitLoss
-2154084
CY2021 us-gaap Profit Loss
ProfitLoss
-2252766
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7048
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1160446
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2154084
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-2245718
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11675216
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11675216
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11675216
CY2023 us-gaap Profit Loss
ProfitLoss
-1160446
CY2022 us-gaap Profit Loss
ProfitLoss
-2154084
CY2021 us-gaap Profit Loss
ProfitLoss
-2252766
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
108520
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-101200
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
94694
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1051926
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2255284
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2158072
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
143
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1051926
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2255284
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2158215
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9115488
CY2021 us-gaap Profit Loss
ProfitLoss
-2252766
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
94694
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6957416
CY2022 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
226999
CY2022 us-gaap Profit Loss
ProfitLoss
-2154084
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-101200
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4929131
CY2023 us-gaap Profit Loss
ProfitLoss
-1160446
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
108520
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3877205
CY2023 us-gaap Profit Loss
ProfitLoss
-1160446
CY2022 us-gaap Profit Loss
ProfitLoss
-2154084
CY2021 us-gaap Profit Loss
ProfitLoss
-2252766
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76246
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36243
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24910
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-159509
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
165464
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59625
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
18762
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
43548
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14402
CY2023 mdjh Translation Adjustment Reporting To Functional Currency Gain Loss Duration
TranslationAdjustmentReportingToFunctionalCurrencyGainLossDuration
80887
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
10954
CY2022 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-240431
CY2021 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
-8350
CY2021 mdjh Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
103459
CY2023 mdjh Disposal Group Including Discontinued Operation Interest Expense Income
DisposalGroupIncludingDiscontinuedOperationInterestExpenseIncome
-5026
CY2022 mdjh Disposal Group Including Discontinued Operation Interest Expense Income
DisposalGroupIncludingDiscontinuedOperationInterestExpenseIncome
21241
CY2021 mdjh Disposal Group Including Discontinued Operation Interest Expense Income
DisposalGroupIncludingDiscontinuedOperationInterestExpenseIncome
5327
CY2023 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-10835
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-3020
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-9963
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-935537
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-815839
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1969361
CY2023 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2051
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
2788
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-16190
CY2023 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-15726
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-5914
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
2664
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-207250
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-537442
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-162279
CY2023 mdjh Increase Decrease In Value Added And Other Taxes Payable
IncreaseDecreaseInValueAddedAndOtherTaxesPayable
-5637
CY2022 mdjh Increase Decrease In Value Added And Other Taxes Payable
IncreaseDecreaseInValueAddedAndOtherTaxesPayable
-125453
CY2021 mdjh Increase Decrease In Value Added And Other Taxes Payable
IncreaseDecreaseInValueAddedAndOtherTaxesPayable
-85526
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-46474
CY2023 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1847
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3841
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-599365
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1587117
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-334281
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3095291
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
106544
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
45507
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
6600
CY2021 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
71035
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1384
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
30607
CY2023 mdjh Disposal Group Including Discontinued Operation Consideration Proceeds From Repayment
DisposalGroupIncludingDiscontinuedOperationConsiderationProceedsFromRepayment
66376
CY2022 mdjh Disposal Group Including Discontinued Operation Consideration Proceeds From Repayment
DisposalGroupIncludingDiscontinuedOperationConsiderationProceedsFromRepayment
742
CY2021 mdjh Disposal Group Including Discontinued Operation Consideration Proceeds From Repayment
DisposalGroupIncludingDiscontinuedOperationConsiderationProceedsFromRepayment
23724
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38784
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3109449
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53911
CY2023 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-363089
CY2022 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
381754
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-363089
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
381754
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
71585
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4288
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22224
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-929653
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4310524
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-365968
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1433158
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6110046
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
503505
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1433158
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
499654
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1358838
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4796299
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3851
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
74320
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
947779
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
503505
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1433158
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5744078
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5256
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
23553
CY2023 us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
5744078
CY2023 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
396
CY2023 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
5743682
CY2018Q2 mdjh Business Agreement Term
BusinessAgreementTerm
P10Y
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of these consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from such estimates. Significant accounting estimates reflected in the Group’s financial statements include useful lives and valuation of long-lived assets, allowance for doubtful accounts, assumptions related to the consolidation of entities in which the Group holds variable interests, and valuation allowance on deferred tax.</p>
CY2021Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.7419
CY2023Q4 mdjh Annual Average Foreign Currency Exchange Rate Translation
AnnualAverageForeignCurrencyExchangeRateTranslation
0.8039
CY2022Q4 mdjh Annual Average Foreign Currency Exchange Rate Translation
AnnualAverageForeignCurrencyExchangeRateTranslation
0.8121
CY2021Q4 mdjh Annual Average Foreign Currency Exchange Rate Translation
AnnualAverageForeignCurrencyExchangeRateTranslation
0.7327
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
18762
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
43548
CY2023Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
65
CY2022Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
74320
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023 mdjh Value Added Tax Standard Rate Percent
ValueAddedTaxStandardRatePercent
0.20
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.19
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
mdjh Small Profits Rate Of Corporation Tax
SmallProfitsRateOfCorporationTax
0.19
CY2023 mdjh Maximum Amount Of Profits For Small Profits Rate Of Corporation Tax
MaximumAmountOfProfitsForSmallProfitsRateOfCorporationTax
50000
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.8315
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
126082
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
126082
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.25
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.51
CY2023 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1160446
CY2022 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2154084
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11675216
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11675216
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
7.0999
CY2022Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
6.8987
CY2021Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
6.3524
CY2023Q4 mdjh Annual Average Foreign Currency Exchange Rate Translation
AnnualAverageForeignCurrencyExchangeRateTranslation
7.0809
CY2022Q4 mdjh Annual Average Foreign Currency Exchange Rate Translation
AnnualAverageForeignCurrencyExchangeRateTranslation
6.7347
CY2021Q4 mdjh Annual Average Foreign Currency Exchange Rate Translation
AnnualAverageForeignCurrencyExchangeRateTranslation
6.4491
CY2023Q4 us-gaap Foreign Currency Exchange Rate Translation1
ForeignCurrencyExchangeRateTranslation1
0.7847
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-14402
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Concentration Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s business, financial condition, and results of operations in the PRC may be influenced by the political, economic, and legal environment in the PRC, and by the general state of the economy of the PRC. The Company’s operations in the PRC are subject to specific considerations and significant risks not typically associated with companies in North America. The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion and remittance abroad, and rates and methods of taxation, among other things. Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and trade accounts receivable. All of the Company’s cash in the PRC is maintained with state-owned banks within the PRC. Per PRC regulations, the maximum insured bank deposit amount is approximately $70,424 (RMB500,000) for each depositor. The Company’s total unprotected cash in the PRC banks amounted to approximately $0 and $5,225 as of December 31, 2023 and 2022, respectively. The Company has not experienced any losses in such accounts and believes it is not exposed to any risks on its cash in bank accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s subsidiaries in the UK have bank accounts in the UK. Customer deposits held by banks, building societies and credit unions (including in Northern Ireland) in UK establishments that are authorized by the Prudential Regulation Authority (PRA) are protected by the Financial Services Compensation Scheme (FSCS) up to GBP85,000, which was approximately $108,322. The Company’s total unprotected cash in bank amounted to approximately $367,949 and $1,135,013, as of December 31, 2023 and 2022, respectively. The Company has not experienced any losses in such accounts and believes it is not exposed to any risks on its cash in bank accounts.</p>
CY2023 mdjh Maximum Insured Bank Deposit
MaximumInsuredBankDeposit
70424
CY2023 mdjh Maximum Insured Bank Deposit
MaximumInsuredBankDeposit
500000
CY2023 mdjh Total Unprotected Cash In Bank
TotalUnprotectedCashInBank
0
CY2022 mdjh Total Unprotected Cash In Bank
TotalUnprotectedCashInBank
5225
CY2023 mdjh Financial Services Compensation Cost
FinancialServicesCompensationCost
85000
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
211369
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1199756
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47199
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
231937
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164170
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
967819
mdjh Taxable Income On Small Business
TaxableIncomeOnSmallBusiness
3000000
mdjh Number Of Employee
NumberOfEmployee
300
CY2022Q4 us-gaap Assets
Assets
50000000
CY2023 mdjh Number Of Major Customer
NumberOfMajorCustomer
1
CY2023 mdjh Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.28
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
0
CY2022 mdjh Number Of Major Customer
NumberOfMajorCustomer
1
CY2022 mdjh Concentration Risk Threshold Percentage
ConcentrationRiskThresholdPercentage
0.79
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
80159
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3424079
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3192310
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
116708
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62426
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3307371
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3129884
CY2023 us-gaap Depreciation
Depreciation
76246
CY2022 us-gaap Depreciation
Depreciation
36243
CY2021 us-gaap Depreciation
Depreciation
24910
CY2023 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1384
CY2023 mdjh Property Plant And Equipment Disposals Net
PropertyPlantAndEquipmentDisposalsNet
1396
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-12
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
5949
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
4553
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
30607
CY2022 mdjh Property Plant And Equipment Disposals Net
PropertyPlantAndEquipmentDisposalsNet
19653
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
10954
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
103360
CY2022 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
83707
CY2023Q4 mdjh Corporation Tax Rate
CorporationTaxRate
0.19
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.19
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25
CY2023 mdjh Small Profits Rate Of Corporation Tax
SmallProfitsRateOfCorporationTax
0.19
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
10835
CY2022 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
3020
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
9963
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10835
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3020
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9963
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
11800
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
17602
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
475900
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
302238
CY2023Q4 mdjh Deferred Tax Items Accrued Expenses
DeferredTaxItemsAccruedExpenses
110215
CY2022Q4 mdjh Deferred Tax Items Accrued Expenses
DeferredTaxItemsAccruedExpenses
41141
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
597915
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
360981
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
597915
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
349860
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11121
CY2023 mdjh Period For Statute Of Limitations Underpayment Of Income Taxes Due To Computational Errors
PeriodForStatuteOfLimitationsUnderpaymentOfIncomeTaxesDueToComputationalErrors
P3Y
CY2023 mdjh Period For Statute Of Limitations Under Special Circumstances
PeriodForStatuteOfLimitationsUnderSpecialCircumstances
P5Y
CY2023Q4 mdjh Maximum Amount Of Underpayment Of Tax Liability
MaximumAmountOfUnderpaymentOfTaxLiability
100000
CY2023Q4 mdjh Maximum Amount Of Underpayment Of Tax Liability
MaximumAmountOfUnderpaymentOfTaxLiability
14000
CY2023 mdjh Period For Statute Of Limitations Underpayment Of Tax Liability Exceeds Rmb100000
PeriodForStatuteOfLimitationsUnderpaymentOfTaxLiabilityExceedsRmb100000
P10Y
CY2021 mdjh Provision For Income Tax Uncertainty
ProvisionForIncomeTaxUncertainty
0
CY2023Q3 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
183
CY2023Q3 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
4000
CY2023Q3 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1300
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 mdjh Provision For Income Tax Uncertainty
ProvisionForIncomeTaxUncertainty
0
CY2023 mdjh Provision For Income Tax Uncertainty
ProvisionForIncomeTaxUncertainty
0
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
82494
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
42805
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
18603
CY2022Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
109829
CY2023Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
872
CY2022Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
160452
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
101969
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
313086
CY2023Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0435
CY2019Q4 mdjh Non Cash Operating Lease Right Of Use Asset
NonCashOperatingLeaseRightOfUseAsset
479744
CY2019Q4 mdjh Non Cash Operating Lease Right Of Use Asset
NonCashOperatingLeaseRightOfUseAsset
3342278
CY2019Q4 mdjh Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
479744
CY2019Q4 mdjh Non Cash Operating Lease Liability
NonCashOperatingLeaseLiability
3342278
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
1214
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
0
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
3715
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
0
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
0
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
117686
CY2023Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2113
CY2023Q2 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
15000
CY2023Q3 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
563
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.25
CY2019Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
190384
CY2022Q4 mdjh Statutory Reserves
StatutoryReserves
327140
CY2023Q4 mdjh Statutory Reserves
StatutoryReserves
327140
CY2023 mdjh Percentage Of Real Estate Agent Income Declined
PercentageOfRealEstateAgentIncomeDeclined
0.9034
CY2022 mdjh Percentage Of Real Estate Agent Income Declined
PercentageOfRealEstateAgentIncomeDeclined
0.8971
CY2021 mdjh Percentage Of Real Estate Agent Income Declined
PercentageOfRealEstateAgentIncomeDeclined
0.2855
CY2022Q4 mdjh Amount Of Liquidated Damages And Interest
AmountOfLiquidatedDamagesAndInterest
5157182
CY2023Q1 mdjh Company Received Payment
CompanyReceivedPayment
838625
CY2023Q1 mdjh Company Received Payment
CompanyReceivedPayment
5954151
CY2023Q3 mdjh Alleging Breach Of Contracts Against Individual
AllegingBreachOfContractsAgainstIndividual
101692
CY2023Q3 mdjh Alleging Breach Of Contracts Against Individual
AllegingBreachOfContractsAgainstIndividual
722000
CY2023Q3 mdjh Litigation Settlement Amount Agreed To Claim From Other Party
LitigationSettlementAmountAgreedToClaimFromOtherParty
63381
CY2023Q3 mdjh Litigation Settlement Amount Agreed To Claim From Other Party
LitigationSettlementAmountAgreedToClaimFromOtherParty
450000
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
1397
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
9919
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
38310
CY2023Q3 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
272000
CY2023Q3 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
64778
CY2023Q3 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
459919
CY2023 us-gaap Revenues
Revenues
144863
CY2023 mdjh Percentage Of Revenue On Consolidated Revenue
PercentageOfRevenueOnConsolidatedRevenue
1
CY2022 us-gaap Revenues
Revenues
450634
CY2022 mdjh Percentage Of Revenue On Consolidated Revenue
PercentageOfRevenueOnConsolidatedRevenue
1
CY2021 us-gaap Revenues
Revenues
4466233
CY2021 mdjh Percentage Of Revenue On Consolidated Revenue
PercentageOfRevenueOnConsolidatedRevenue
1
CY2023 us-gaap Revenues
Revenues
144863
CY2023 mdjh Percentage Of Revenue On Consolidated Revenue
PercentageOfRevenueOnConsolidatedRevenue
1
CY2022 us-gaap Revenues
Revenues
450634
CY2022 mdjh Percentage Of Revenue On Consolidated Revenue
PercentageOfRevenueOnConsolidatedRevenue
1
CY2021 us-gaap Revenues
Revenues
4466233
CY2021 mdjh Percentage Of Revenue On Consolidated Revenue
PercentageOfRevenueOnConsolidatedRevenue
1
CY2023Q4 us-gaap Assets
Assets
3999242
CY2023 mdjh Percentage Of Value Of Assets On Consolidated Assets
PercentageOfValueOfAssetsOnConsolidatedAssets
1
CY2022Q4 us-gaap Assets
Assets
5635075
CY2022 mdjh Percentage Of Value Of Assets On Consolidated Assets
PercentageOfValueOfAssetsOnConsolidatedAssets
1
CY2021Q4 us-gaap Assets
Assets
8368970
CY2021 mdjh Percentage Of Value Of Assets On Consolidated Assets
PercentageOfValueOfAssetsOnConsolidatedAssets
1

Files In Submission

Name View Source Status
0001410578-24-000556-index-headers.html Edgar Link pending
R37.htm Edgar Link pending
0001410578-24-000556-index.html Edgar Link pending
0001410578-24-000556.txt Edgar Link pending
0001410578-24-000556-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdjh-20231231.xsd Edgar Link pending
mdjh-20231231x20f.htm Edgar Link pending
mdjh-20231231x20f001.jpg Edgar Link pending
mdjh-20231231xex12d1.htm Edgar Link pending
mdjh-20231231xex12d2.htm Edgar Link pending
mdjh-20231231xex13d1.htm Edgar Link pending
mdjh-20231231xex13d2.htm Edgar Link pending
mdjh-20231231xex15d1.htm Edgar Link pending
mdjh-20231231xex15d2.htm Edgar Link pending
mdjh-20231231xex8d1.htm Edgar Link pending
mdjh-20231231xex97d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
mdjh-20231231_cal.xml Edgar Link unprocessable
mdjh-20231231x20f_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mdjh-20231231_def.xml Edgar Link unprocessable
mdjh-20231231_lab.xml Edgar Link unprocessable
mdjh-20231231_pre.xml Edgar Link unprocessable